Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial dynamics refers to the regulated processes of fission (division) and fusion (joining) of mitochondria, as well as their transport and turnover (mitophagy), which are critical for mitochondrial function, cellular energy production, quality control, and cell fate. These processes are orchestrated by key GTPase proteins (DRP1, MFN1, MFN2, OPA1) and their adaptors, whose activity is tightly controlled by cellular signaling and whose dysfunction is implicated in a wide range of human diseases including cancer, neurodegeneration, and metabolic syndrome[1][2][3][4][5][7][8]. While several components of mitochondrial dynamics present promising drug targets, the pathway itself is a system-level process and not a singular molecular entity.
Inhibition of GTPase activity of fusion/fission proteins (e.g., DRP1, OPA1) Modulation of mitochondrial oxidative phosphorylation Scavenging of mitochondrial reactive oxygen species (ROS) Promotion of mitochondrial biogenesis (e.g., via PGC-1α activation) Modulation of mitochondrial quality control and apoptotic signaling
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial dynamics pathway.